These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [The role of allopurinol in prevention of recurrences in calcic calculosis]. Fiorelli C, Carini M, Nicita G, Rizzo M. Minerva Urol; 1980 Mar 07; 32(3):153-60. PubMed ID: 7432330 [No Abstract] [Full Text] [Related]
11. [Calcium lithiasis: uric acid under question]. Petit C. Nephrologie; 1984 Mar 07; 5(5):192-4. PubMed ID: 6531055 [Abstract] [Full Text] [Related]
12. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY, Sakhaee K, Fuller CJ. Trans Assoc Am Physicians; 1983 Mar 07; 96():294-305. PubMed ID: 6679957 [Abstract] [Full Text] [Related]
13. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM. J Urol; 2004 Jul 07; 172(1):159-63. PubMed ID: 15201761 [Abstract] [Full Text] [Related]
14. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. J Urol; 1996 Mar 07; 155(3):839-43. PubMed ID: 8583588 [Abstract] [Full Text] [Related]